UBR5 and neoplasm: Both tumor size (Figure 5A) and weight (Figure 5C) were significantly lower for UBR5 shRNA-expressing cells than those of control animals at 20-21 days after injection, and reduced UBR5 expression was maintained in the tumor tissues until the end of the experiment (Figure 5D).